Defining the Value of Medicine in an Evidence-Based Healthcare M...(d at industry executives in all areas of...),Health

Date:11/26/2007

d at industry executives in all areas of responsibility who want to create successful strategies for dealing with FDA and CMS. Attendees will get practical, real-life lessons from some of the most experienced pharmaceutical and biotechnology executives on handling regulatory obstacles and on identifying opportunities in the current dynamic environment. The conference will also provide a forum for attendees to benchmark their regulatory strategy against all other pharmaceutical and biotechnology companies.

Among the panels and participants scheduled to address value of medicine during the Summit are:
-- Personalized Medicine: How Industry and Government Can Make it Happen

George Abercrombie - CEO, Hoffmann La-Roche, Inc.

-- Keynote Address

Tevi D. Troy - Deputy Secretary, HHS

-- Paying for Innovation: CMS' Approach to Coverage

Steve Phurrough - CMS Coverage & Analysis Group Director

-- Coverage Policy and Value Demonstration - An Industry Perspective

Josh Ofman - VP Global Reimbursement, Amgen

-- How the Government and Payors will Impact the Rx Market

Larry Kocot - Former CMS Senior Advisor

Robert Seidman - Former Wellpoint Chief Pharmacy Officer and Founder

of Doc Rock Presents

-- Pharmaceutical Pricing Legislation: What does Industry Need to do to

Prepare?

Brian Cohen - House Oversight and Government Reform Committee Staff

Stephen Schondelmeyer, Pharm.D., Ph.D. - Director, PRIME Institute

Joseph R. Antos - Wilson H. Taylor Scholar on Health Care and

Retirement Policy, American Enterprise Institute

Complete agenda and registration information are available at http://www.windhover.com/fda-cms.

The RPM Report is a unique Windhover publication that examines FDA and CMS from a business perspective, designed to deliver not only the new
'/>"/>

SOURCE Windhover Information Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. ZIP codes and property values predict obesity rates
2. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
3. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
4. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
5. Study Questions Flu Shots Value for Older People
6. Glycemic index values are variable, report researchers
7. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
8. Boston Scientific Announces New Initiatives to Increase Shareholder Value
9. Value of Most Post-Traumatic Stress Treatments Uncertain
10. Joint Juice Helps America Hydrate Its Joints* With New High Value Coupon Offer
11. What is a critical lab value? it depends, Hopkins researchers find